Action Potential Venture Capital

Action Potential Venture Capital

A venture capital firm in Massachusetts that focuses on investing in bioelectronic medicine and technology companies.

Action Potential Venture Capital is a venture capital firm in Massachusetts that focuses on investing in bioelectronic medicine and technology companies. Founded in Cambridge, Massachusetts, United States, it invests in early stage ventures. Action Potential Venture Capital (APVC) Limited is a new $50 million strategic venture capital fund backed by GlaxoSmithKline. The fund’s first investment was in SetPoint Medical, a California company considered a trailblazer in creating implantable devices to treat inflammatory diseases. The fund complements the work of GSK’s Bioelectronics R&D unit, which was established in 2012 after a two-year effort to seek out and engage the most promising researchers in this emerging area of science. Its portfolio companies include CVRx, Cala Health, NeuSpera Medical, SetPoint Medical, and Saluda Medical. As of March 2020, Action Potential Venture Capital has made nine investments. Their most recent investment was on June 3, 2019, when CVRx raised $93M.

Timeline

2013
Founded

Funded Companies

Company
Description
Industry
Website
Location
SetPoint Medical

A company developing implantable devices to treat inflammatory diseases

Neuspera Medical is a San Jose, California-based medical device company.

3 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Imran Eba

Partner

Juan-Pablo Mas

Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Cala Health

CVRx

SetPoint Medical

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.